Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

被引：0
|
作者：
Coles, AJ
Paolillo, A
Molyneux, P
Wing, MG
Hale, G
Miller, D
Waldmann, H
Compston, DAS
机构：
来源：
ANNALS OF NEUROLOGY | 1998年 / 44卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M92
引用
收藏
页码：464 / 464
页数：1
相关论文
共 50 条
  • [31] Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
    Elsbernd, Paul M.
    Carter, Jonathan L.
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 255 - 263
  • [32] Multiple sclerosis - candidate mechanisms underlying CNS atrophy
    Siffrin, Volker
    Vogt, Johannes
    Radbruch, Helena
    Nitsch, Robert
    Zipp, Frauke
    TRENDS IN NEUROSCIENCES, 2010, 33 (04) : 202 - 210
  • [33] Development of Anti-SEMA4D Monoclonal Antibody for the Treatment of Multiple Sclerosis
    Smith, Ernest S.
    Fisher, Terrence
    Cornelius, Chad
    Reilly, Christine
    Winter, Laurie
    Veeraraghaven, Janaki
    Jonason, Alan
    Scrivens, Maria
    Parker, Robert
    Seils, Jennifer
    Kirk, Renee
    Richards, Troy
    Caplan, Jeffrey
    Kenney, Patrick
    Croy, Leslie
    Pandina, Tracy
    Torno, Sebold
    Evans, Elizabeth
    Paris, Mark
    Leonard, John
    Watkins, Raymond
    Foster, Paul
    Zauderer, Maurice
    NEUROLOGY, 2011, 76 (09) : A646 - A646
  • [34] Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
    Fisher, T.
    Reilly, C.
    Winter, L.
    Veeraraghavan, J.
    Jonason, A.
    Seils, J.
    Huang, H.
    Bussler, H.
    Klimatcheva, E.
    Decker, J.
    Torno, S.
    Kirk, R.
    Cornelius, C.
    Richards, T.
    Caplan, J.
    Howell, A.
    Kenney, P.
    Scrivens, M.
    Croy, L.
    Pandina, T.
    Doherty, M.
    Seigel, G.
    Evans, E.
    Paris, M.
    Leonard, J.
    Watkins, R.
    Foster, P.
    Zauderer, M.
    Smith, E.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S206 - S206
  • [35] Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
    Fisher, T.
    Reilly, C.
    Winter, L.
    Veeraraghavan, J.
    Jonason, A.
    Seils, J.
    Huang, H.
    Bussler, H.
    Klimatcheva, E.
    Decker, J.
    Torno, S.
    Kirk, R.
    Cornelius, C.
    Richards, T.
    Caplan, J.
    Howell, A.
    Kenney, P.
    Scrivens, M.
    Croy, L.
    Pandina, T.
    Doherty, M.
    Seigel, G.
    Wang, W.
    Evans, E.
    Bowers, W.
    Paris, M.
    Leonard, J.
    Watkins, R.
    Foster, P.
    Zauderer, M.
    Smith, E.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 444 - 444
  • [36] Clinical effects of natalizumab on multiple sclerosis appear early in treatment course
    Ludwig Kappos
    Paul W. O’Connor
    Christopher H. Polman
    Patrick Vermersch
    Heinz Wiendl
    Amy Pace
    Annie Zhang
    Christophe Hotermans
    Journal of Neurology, 2013, 260 : 1388 - 1395
  • [37] Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
    Jonason, A.
    Klimatcheva, E.
    Fisher, T.
    Reilly, C.
    Winter, L.
    Veeraraghavan, J.
    Seils, J.
    Huang, H.
    Bussler, H.
    Decker, J.
    Torno, S.
    Kirk, R.
    Cornelius, C.
    Richards, T.
    Caplan, J.
    Howell, A.
    Kenney, P.
    Scrivens, M.
    Balch, L.
    Pandina, T.
    Doherty, M.
    Seigel, G.
    Wang, W.
    Evans, E.
    Bowers, W.
    Paris, M.
    Leonard, J.
    Watkins, R.
    Foster, P.
    Zauderer, M.
    Smith, E.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 240 - 241
  • [38] Clinical effects of natalizumab on multiple sclerosis appear early in treatment course
    Kappos, Ludwig
    O'Connor, Paul W.
    Polman, Christopher H.
    Vermersch, Patrick
    Wiendl, Heinz
    Pace, Amy
    Zhang, Annie
    Hotermans, Christophe
    JOURNAL OF NEUROLOGY, 2013, 260 (05) : 1388 - 1395
  • [39] HLA IN MULTIPLE-SCLEROSIS - RELATIONSHIP TO MEASLES ANTIBODY, MITOGEN RESPONSIVENESS AND CLINICAL COURSE
    PATY, DW
    DOSSETOR, JB
    STILLER, CR
    COUSIN, HK
    MARCHUK, L
    FURESZ, J
    BOUCHER, DW
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1977, 32 (03) : 371 - 379
  • [40] Anti-LINGO-1 monoclonal antibody Treatment of multiple sclerosis Treatment of acute optic neuritis
    Haddley, K.
    DRUGS OF THE FUTURE, 2015, 40 (09) : 569 - 574
12345